List of Tables
    Table 1. Duchenne Muscular Dystrophy Drugs Market Opportunities & Trends in Global Market
    Table 2. Duchenne Muscular Dystrophy Drugs Market Drivers in Global Market
    Table 3. Duchenne Muscular Dystrophy Drugs Market Restraints in Global Market
    Table 4. Key Players of Duchenne Muscular Dystrophy Drugs in Global Market
    Table 5. Top Duchenne Muscular Dystrophy Drugs Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Duchenne Muscular Dystrophy Drugs Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Duchenne Muscular Dystrophy Drugs Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Duchenne Muscular Dystrophy Drugs Product Type
    Table 9. List of Global Tier 1 Duchenne Muscular Dystrophy Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Duchenne Muscular Dystrophy Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Duchenne Muscular Dystrophy Drugs Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Duchenne Muscular Dystrophy Drugs Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Duchenne Muscular Dystrophy Drugs Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Duchenne Muscular Dystrophy Drugs Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Duchenne Muscular Dystrophy Drugs Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Duchenne Muscular Dystrophy Drugs Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2023-2028
    Table 30. Biogen Corporate Summary
    Table 31. Biogen Duchenne Muscular Dystrophy Drugs Product Offerings
    Table 32. Biogen Duchenne Muscular Dystrophy Drugs Revenue (US$, Mn), (2017-2022)
    Table 33. Roche Corporate Summary
    Table 34. Roche Duchenne Muscular Dystrophy Drugs Product Offerings
    Table 35. Roche Duchenne Muscular Dystrophy Drugs Revenue (US$, Mn), (2017-2022)
    Table 36. Daiichi Sankyo Corporate Summary
    Table 37. Daiichi Sankyo Duchenne Muscular Dystrophy Drugs Product Offerings
    Table 38. Daiichi Sankyo Duchenne Muscular Dystrophy Drugs Revenue (US$, Mn), (2017-2022)
    Table 39. Pfizer Corporate Summary
    Table 40. Pfizer Duchenne Muscular Dystrophy Drugs Product Offerings
    Table 41. Pfizer Duchenne Muscular Dystrophy Drugs Revenue (US$, Mn), (2017-2022)
    Table 42. Cumberland Pharmaceuticals Corporate Summary
    Table 43. Cumberland Pharmaceuticals Duchenne Muscular Dystrophy Drugs Product Offerings
    Table 44. Cumberland Pharmaceuticals Duchenne Muscular Dystrophy Drugs Revenue (US$, Mn), (2017-2022)
    Table 45. Santhera Pharmaceuticals Corporate Summary
    Table 46. Santhera Pharmaceuticals Duchenne Muscular Dystrophy Drugs Product Offerings
    Table 47. Santhera Pharmaceuticals Duchenne Muscular Dystrophy Drugs Revenue (US$, Mn), (2017-2022)
    Table 48. Taiho Pharmaceutical Corporate Summary
    Table 49. Taiho Pharmaceutical Duchenne Muscular Dystrophy Drugs Product Offerings
    Table 50. Taiho Pharmaceutical Duchenne Muscular Dystrophy Drugs Revenue (US$, Mn), (2017-2022)
    Table 51. Teijin Pharma Corporate Summary
    Table 52. Teijin Pharma Duchenne Muscular Dystrophy Drugs Product Offerings
    Table 53. Teijin Pharma Duchenne Muscular Dystrophy Drugs Revenue (US$, Mn), (2017-2022)
    Table 54. Akashi Therapeutics Corporate Summary
    Table 55. Akashi Therapeutics Duchenne Muscular Dystrophy Drugs Product Offerings
    Table 56. Akashi Therapeutics Duchenne Muscular Dystrophy Drugs Revenue (US$, Mn), (2017-2022)
    Table 57. Sarepta Therapeutics Corporate Summary
    Table 58. Sarepta Therapeutics Duchenne Muscular Dystrophy Drugs Product Offerings
    Table 59. Sarepta Therapeutics Duchenne Muscular Dystrophy Drugs Revenue (US$, Mn), (2017-2022)
    Table 60. BioMarin Corporate Summary
    Table 61. BioMarin Duchenne Muscular Dystrophy Drugs Product Offerings
    Table 62. BioMarin Duchenne Muscular Dystrophy Drugs Revenue (US$, Mn), (2017-2022)
    Table 63. Fibrogen Inc Corporate Summary
    Table 64. Fibrogen Inc Duchenne Muscular Dystrophy Drugs Product Offerings
    Table 65. Fibrogen Inc Duchenne Muscular Dystrophy Drugs Revenue (US$, Mn), (2017-2022)
    Table 66. Nobelpharma Co. Ltd Corporate Summary
    Table 67. Nobelpharma Co. Ltd Duchenne Muscular Dystrophy Drugs Product Offerings
    Table 68. Nobelpharma Co. Ltd Duchenne Muscular Dystrophy Drugs Revenue (US$, Mn), (2017-2022)
    Table 69. Eloxx Pharmaceuticals Corporate Summary
    Table 70. Eloxx Pharmaceuticals Duchenne Muscular Dystrophy Drugs Product Offerings
    Table 71. Eloxx Pharmaceuticals Duchenne Muscular Dystrophy Drugs Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Duchenne Muscular Dystrophy Drugs Segment by Type in 2021
    Figure 2. Duchenne Muscular Dystrophy Drugs Segment by Application in 2021
    Figure 3. Global Duchenne Muscular Dystrophy Drugs Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Duchenne Muscular Dystrophy Drugs Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Duchenne Muscular Dystrophy Drugs Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Duchenne Muscular Dystrophy Drugs Revenue in 2021
    Figure 8. By Type - Global Duchenne Muscular Dystrophy Drugs Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Duchenne Muscular Dystrophy Drugs Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Duchenne Muscular Dystrophy Drugs Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Duchenne Muscular Dystrophy Drugs Revenue Market Share, 2017-2028
    Figure 12. US Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Duchenne Muscular Dystrophy Drugs Revenue Market Share, 2017-2028
    Figure 16. Germany Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2017-2028
    Figure 17. France Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Duchenne Muscular Dystrophy Drugs Revenue Market Share, 2017-2028
    Figure 24. China Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2017-2028
    Figure 28. India Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Duchenne Muscular Dystrophy Drugs Revenue Market Share, 2017-2028
    Figure 30. Brazil Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Duchenne Muscular Dystrophy Drugs Revenue Market Share, 2017-2028
    Figure 33. Turkey Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Duchenne Muscular Dystrophy Drugs Revenue, (US$, Mn), 2017-2028
    Figure 37. Biogen Duchenne Muscular Dystrophy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Roche Duchenne Muscular Dystrophy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Daiichi Sankyo Duchenne Muscular Dystrophy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Pfizer Duchenne Muscular Dystrophy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Cumberland Pharmaceuticals Duchenne Muscular Dystrophy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Santhera Pharmaceuticals Duchenne Muscular Dystrophy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Taiho Pharmaceutical Duchenne Muscular Dystrophy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Teijin Pharma Duchenne Muscular Dystrophy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Akashi Therapeutics Duchenne Muscular Dystrophy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Sarepta Therapeutics Duchenne Muscular Dystrophy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. BioMarin Duchenne Muscular Dystrophy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 48. Fibrogen Inc Duchenne Muscular Dystrophy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 49. Nobelpharma Co. Ltd Duchenne Muscular Dystrophy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 50. Eloxx Pharmaceuticals Duchenne Muscular Dystrophy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)